how long has glp 1 been around GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness GLP-1 Medications: Access, Affordability, and

Review the sources used below for this article: This article references information from the KFF (Kaiser Family Foundation) Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford This article references information from the FDA: FDA Approves First Treatment to Reduce Risk of Serious Heart Problems, Specifically in Adults with Obesity or Overweight This article references information from a recent study published in The New England Journal of Medicine : Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity This article references information from the American College of Cardiology: OASIS 4: Significant Weight Loss With Oral Semaglutide Comparable With High-Dose, SC Versions This article references information from Reuters: Lilly will have supply of new weight loss pill for many countries, exec says

Lancet 405 , 627636 (2025)

evaluated the effect of semaglutide in a 52-week randomized, double-blinded, placebo-controlled trial involving adults with increased fracture risk

Additionally, oral bioavailability is a major hurdle

These include potential benefits in obesity management and even cardiovascular disease prevention in non-diabetic patients